M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to ...
马萨诸塞州沃尔瑟姆讯 - 全球科学服务领军企业Thermo Fisher Scientific Inc.(NYSE: TMO)宣布达成最终协议,将以41亿美元现金收购Solventum(NYSE: SOLV)旗下的净化与过滤业务部门。此次战略性收购将增强Thermo Fisher的生物制品生产能力,并扩大其在快速增长的生物制程市场的影响力。
Thermo Fisher Scientific is nearing a deal for Solventum’s purification and filtration business, according to people familiar ...
生物科技公司Thermo Fisher Scientific (TMO.US) 周二宣布,将以约41亿美元的现金购买Solventum (SOLV.US) 的净化与过滤业务。Solventum股价早段涨9%。
Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration ...
Thermo Fisher董事长、总裁兼首席执行官Marc N. Casper表示,收购Solventum的业务在战略上与公司高度契合,将为客户和股东创造可观价值。他强调,Solventum的解决方案将受到客户欢迎,并进一步展示Thermo Fisher严谨的资本部署战略,这一战略在创造股东价值方面已有良好记录。
7 天
GlobalData on MSNThermo Fisher strikes $4.1bn deal for Solventum’s purification and filtration unitGlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a ...
The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, ...
Companies confirm deal details. Thermo Fisher Scientific (NYSE:TMO) confirmed that it agreed to purchase Solventum's ...
Thermo Fisher Scientific agreed to pay about $4.1 billion in cash to acquire Solventum’s purification and filtration business ...
Highly Complementary to Thermo Fisher’s Bioproduction Business and Strengthens Offering in the High Growth Bioprocessing Market Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果